#Unilever Acquires Grüns in Health Expansion
Unilever (LSE: ULVR) said Thursday it has agreed to acquire U.S.-based supplements company Grüns for an undisclosed amount, marking its latest move to expand in the health and wellness segment.
The acquisition follows a broader strategic shift by the consumer goods group toward higher-growth categories such as wellbeing and beauty. It also comes shortly after Unilever outlined plans to merge its food business with McCormick, a transaction expected to create a combined entity valued at approximately $65 billion.
#Expansion of Wellbeing Portfolio
Grüns, founded in 2023, produces gummy-based nutritional supplements made from ingredients including fruits and vegetables. The company reached a valuation of $500 million during a Series B funding round in 2025, according to the announcement.
Unilever said the addition of Grüns will complement its existing portfolio of supplement and wellness brands, particularly in the United States, where demand for functional nutrition products has grown in recent years.
The company has steadily built its presence in this category through prior acquisitions, including Nutrafol in 2022, SmartyPants Vitamins in 2020, and Olly Nutrition in 2019. These deals reflect a longer-term effort to diversify beyond traditional packaged foods and household products.
Jostein Solheim, head of Unilever’s wellbeing division, said in a statement the company sees potential to expand the Grüns brand within its existing infrastructure. He described the acquisition as part of efforts to scale newer brands within the company’s portfolio.
#Strategic Shift Toward Health and Beauty
The move highlights a broader repositioning underway at Unilever, which has been gradually reducing its reliance on slower-growing food categories while investing in segments tied to personal health, nutrition, and beauty.
Industry analysts have noted that large consumer goods companies are increasingly targeting the supplements market, driven by rising consumer interest in preventative health and convenience-focused formats such as gummies and ready-to-consume products.
Grüns’ product format aligns with these trends, offering an alternative to traditional capsules and powders. However, the supplements sector remains competitive, with a mix of established brands and emerging direct-to-consumer companies seeking market share.
Unilever’s prior acquisitions in the category suggest a strategy focused on scaling smaller, fast-growing brands through its global distribution network. The company has not disclosed financial details of the Grüns transaction, including revenue or profitability metrics.
#Context and Market Considerations
The acquisition comes at a time when multinational consumer goods companies are reassessing portfolio composition in response to shifting consumer behavior and margin pressures in legacy segments.
Unilever’s planned food business combination with McCormick signals a parallel effort to restructure its core operations, potentially allowing greater focus on higher-margin categories such as beauty and wellbeing.
While the supplements market has shown consistent growth, it is also subject to regulatory scrutiny, particularly in the United States, where labeling and health claims are closely monitored. Companies entering or expanding in this space often face compliance requirements that can affect product development and marketing.
Unilever did not provide a timeline for closing the Grüns acquisition or outline integration plans. As with similar transactions, execution will depend on factors including regulatory approvals and the company’s ability to scale operations without diluting brand identity.
The announcement underscores Unilever’s continued shift toward segments it views as offering stronger long-term growth potential, though the financial impact of the deal remains unclear at this stage.